Weight Management in Estonia - New Market Research Report
Alli, an OTC obesity remedy, was withdrawn from the market, resulting in a significant drop in sales. According to company sources, the brand was withdrawn due to the small size of the market. Alli was a quite complicated product, because it had many side effects and needed significant advertising support. OTC obesity sales decreased by 73% in current value terms in 2012 to reach EUR100,000.
View full press release